The Pharmaceutical Index: 2013 Worldwide NCEs

Author:   Ltd. Pharmacodia (Beijing) Co.
Publisher:   CRC Press
ISBN:  

9787506778787


Pages:   546
Publication Date:   28 November 2016
Format:   Hardback
Availability:   To order   Availability explained
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Our Price $1518.00 Quantity:  
Add to Cart

Share |

The Pharmaceutical Index: 2013 Worldwide NCEs


Add your own review!

Overview

An ideal drug candidate should possess good pharmacological activity, absorption, distribution, metabolism, excretion and toxicity properties. Historically, there are around 6,000 drugs being used in humans and approximately 3,000 still in clinical use, not including herbal medicines. This Pharmaceutical Index series focuses on the profiles of 500 pharmaceutically marketed products from the past two decades. Professor Dr. K. Barry Sharpless is Honorary Editor-in-Chief of this first Index by Pharmacodia. The volume includes 24 NCEs worldwide approved drugs in 2013. Pharmacodia plan to publish two further volumes which will feature 2014 NCEs (32 drugs) and 2015 NCEs (25 drugs).

Full Product Details

Author:   Ltd. Pharmacodia (Beijing) Co.
Publisher:   CRC Press
Imprint:   CRC Press
Weight:   2.018kg
ISBN:  

9787506778787


ISBN 10:   7506778785
Pages:   546
Publication Date:   28 November 2016
Audience:   Professional and scholarly ,  College/higher education ,  Professional & Vocational ,  Tertiary & Higher Education
Format:   Hardback
Publisher's Status:   Active
Availability:   To order   Availability explained
Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us.

Table of Contents

Executive Summary Chapter 1: Acotiamide Hydrochloride Hydrate Chapter 2: Afatinib Dimaleate Chapter 3: Canagliflozin Hemihydrate Chapter 4: Cetilistat Chapter 5: Cobicistat Chapter 6: Dabrafenib Mesylate. Chapter 7: Dimethyl Fumarate Chapter 8: Dolutegravir Sodium Chapter 9: Efinaconazole Chapter 10: Elvitegravir Chapter 11: Glycerol Phenylbutyrate Chapter 12: Ibrutinib Chapter 13: Istradefylline Chapter 14: Levomilnacipran Hydrochloride Chapter 15: Macitentan Chapter 16: Olodaterol Hydrochloride Chapter 17: Ospemifene Chapter 18: Pomalidomide Chapter 19: Riociguat Chapter 20: Simeprevir Sodium Chapter 21: Sofosbuvir Chapter 22: Topiroxostat Chapter 23: Trametinib Dimethyl Sulfoxide Chapter 24: Vortioxetine Hydrobromide Appendix I. Abbreviation Appendix II. Worldwide Approved NCEs (2001-2014)

Reviews

'This new series of Pharmaceutical Indexes will be a boon in academia and the pharmaceutical industry, and provide, as well, a significant addition to the therapeutics discovery arsenal. It should also find a wide audience in government, and the business community.' - K. Barry Sharpless, Nobel Prize Winner in Chemistry, 2001. 'The most fruitful basis for the discovery of a new drug is to start with an old drug.' - James W. Black, Nobel Prize Winner in Physiology or Medicine, 1998.


Author Information

Pharmacodia (Beijing) Co. Ltd

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List